iuvo Therapeutics is a pharmaceutical company founded in 2017 and headquartered in Düsseldorf. iuvo’s goal is the reliable supply of high-quality cannabis-based medicines to patients within Europe. iuvo is an independent importer, manufacturer, and wholesaler, constantly expanding its supply chain focusing on established GMP- and GDP-compliant partners. The distribution of our products takes places directly to pharmacies as well as through selected pharmaceutical wholesalers. iuvo develops its pharmaceuticals based on the latest scientific knowledge. In cooperation with experts in cannabis therapy, the company supports doctors and pharmaceutical specialists through recognized scientific training courses. iuvo Therapeutics is also an active member of the Federal Association of Pharmaceutical Cannabinoid Companies.
Potsdam/ Hanover, November 5, 2021 – In collaboration with Prof. Dr. Matthias Karst from the Hannover Medical School (MHH) iuvo Therapeutics GmbH (iuvo Therapeutics or iuvo) is organizing a practice-relevant online training course for doctors on cannabis‑based medicine (CBM) on November 17, 2021. The advanced training course “Insights into an efficient therapy with cannabis-based pharmaceuticals”, […]
Düsseldorf / Frankfurt am Main, November 4, 2021 – iuvo Therapeutics GmbH (iuvo Therapeutics or iuvo) is expanding its sales network: Cansativa GmbH (Cansativa) now offers iuvo’s high-quality full-spectrum cannabis extracts. iuvo Therapeutics and Cansativa have entered into a strategic distribution partnership. The well-established wholesaler with a focus on cannabis-based pharmaceuticals has expanded its product […]
Düsseldorf, October 2021 – iuvo Therapeutics GmbH is proud to announce Alexander Rieg has joined the management team as of October 2021. With his extensive experience in the sales and marketing of pharmaceuticals in Germany, Alexander Rieg founded and acted as managing director of GECA Pharma GmbH. One of the first fully licensed importers of […]